Article
Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Apr 2010
Nicholson Andrew G, Gonzalez David, Shah Pallav, Pynegar Matthew J, Deshmukh Manjiri, Rice Alexandra, Popat Sanjay
Abstract excerpt
INTRODUCTION: The dichotomization of non-small cell carcinoma (NSCLC) subtype into squamous (SQCC) and adenocarcinoma (ADC) has become important in recent years and is increasingly required with regard to management. The aim of this study was to determine the utility of a panel of commercially available antibodies in refining the diagnosis on small biopsies and also to determine whether cytologic material is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.